[Federal Register Volume 84, Number 67 (Monday, April 8, 2019)]
[Notices]
[Pages 13927-13928]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06815]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-19-0009; Docket No. CDC-2019-0014]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled ``National Disease Surveillance
Program--I. Case Reports'' to collect disease-specific surveillance
reports of four rare, uncommon, or infrequent diseases.
DATES: CDC must receive written comments on or before June 7, 2019.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2019-
0014 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal
eRulemaking portal (regulations.gov) or by U.S. mail to the address
listed above.
FOR FURTHER INFORMATION: To request more information on the proposed
project or to obtain a copy of the information collection plan and
instruments, contact Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
National Disease Surveillance Program--I. Case Reports--Revision--
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Surveillance of the incidence and distribution of disease has been
an important function of the US Public Health Service (PHS) since an
1878 Act of Congress authorized the PHS to collect morbidity reports.
After the Malaria Control in War Areas Program had fulfilled its
original 1942 objective of reducing malaria transmission, its basic
tenets were carried forward and broadened by the formation of the
Communicable Disease Center (CDC) in 1946. CDC was conceived of as a
well-equipped, broadly staffed agency used to translate facts about
analysis of morbidity and mortality statistics on communicable diseases
and through field investigations.
It was soon recognized that control measures (such as the DDT
spraying for malaria) did not alleviate the threat of disease
reintroduction. In 1950, the Malaria Surveillance Program began and in
1952, the National Surveillance Program started. Both programs were
based on the premise that diseases cannot be diagnosed, prevented, or
controlled until existing knowledge is expanded and new ideas developed
and implemented. The original scope of the National Surveillance
Program included the study of malaria, murine typhus, smallpox,
psittacosis, diphtheria, leprosy, and sylvatic plague. Over the years,
the mandate of CDC has broadened in preventive health activities and
the surveillance systems maintained have expanded. This program is
authorized under the Public Health Service Act, Section 301 and 306 (42
U.S.C. 241 and 242K).
This ICR covers surveillance activities for these four, rare
diseases:
1. Creutzfeldt-Jakob Disease (CJD)
2. Reye Syndrome
3. Kawasaki syndrome
4. Acute Flaccid Myelitis
Changes are being requested only to the Kawasaki Syndrome form. The
CDC KD form has been used as part of a passive national surveillance
system to collect additional case information, including data on
cardiac complications and treatment. In recent years, new treatments
and/or treatment combinations have been implemented at some
institutions; this information is not collected on the current form.
Also, more specific information regarding the results of coronary
artery testing would be beneficial for assessing disease severity and
treatment effectiveness. To incorporate these additions to the form
without increasing the estimated burden, some current questions on the
form, specifically those collecting information on the presence or
absence of certain complications, will be removed. The form will be
targeted to sentinel KD research centers across the US, reducing the
number of respondents compared to previous years.
Annual burden is estimated to decrease by 53 hours since the last
approval (June, 2019). There is no cost
[[Page 13928]]
to respondents other than the time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Epidemiologists............... CJD............. 10 2 20/60 7
Kawasaki 25 10 15/60 63
Syndrome.
Reye Syndrome... 50 1 20/60 17
Acute Flaccid 100 1 30/60 50
Myelitis.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 137
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-06815 Filed 4-5-19; 8:45 am]
BILLING CODE 4163-18-P